Acta Neuropathologica

Article	Citations
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology	319
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis	205
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease	181
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease	168
Periphery and brain, innate and adaptive immunity in Parkinson’s disease	152
Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains	135
APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease	130
Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study	124
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607	115
Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology	114
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change	110
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function	103
The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models	98
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology	93
Brain arteriolosclerosis	90
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy	89
Tau strains shape disease	87
Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis	83
The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease	81
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology	80
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts	78
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson’s disease brain as revealed by multicolor STED microscopy	76
Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol	72
Analyzing microglial phenotypes across neuropathologies: a practical guide	69
The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis	68

Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis	64
Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons	63
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma	63
Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme	62
Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter	60
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease	59
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential	59
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis	56
Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders	55
Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex	55
LATE-NC staging in routine neuropathologic diagnosis: an update	53
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases	53
TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons	52
Infratentorial IDH-mutant astrocytoma is a distinct subtype	51
The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer’s disease	51
Structure of Tau filaments in Prion protein amyloidoses	51
Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration	51
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers	50
White matter microglia heterogeneity in the CNS	50
Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases	50
Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke	49
Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology	49
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils	49
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts	48
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation	47
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study	46
C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?	45
Selective vulnerability of inhibitory networks in multiple sclerosis	44
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)	42
Subgroup and subtype-specific outcomes in adult medulloblastoma	41
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia	41
Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo	39
Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy	39
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease	39
Supratentorial ependymoma in childhood: more than just RELA or YAP	39
Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation	38
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors	38
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum	37
Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases	37
Retinal pathological features and proteome signatures of Alzheimer’s disease	37
Cryo-EM structures of prion protein filaments from Gerstmann–Sträussler–Scheinker disease	37
The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease	36
Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy	36
Making sense of missense variants in TTN-related congenital myopathies	36
Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases	35
BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy	35
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites	35
A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease	34
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1	34
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations	34

Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory	34
In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics	33
Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders	33
Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains	32
The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease	31
Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy	31
Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging	31
Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders	31
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43	30
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature	30
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease	30
APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology	30
Necrotic reshaping of the glioma microenvironment drives disease progression	29
Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY)	29
Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus–pericoerulear complex by three-dimensional imaging	29
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1	29
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease	29
Mosaic trisomy of chromosome 1q in human brain tissue associates with unilateral polymicrogyria, very early-onset focal epilepsy, and severe developmental delay	29
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease	28
Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis	28
Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids	28
Altered oligodendroglia and astroglia in chronic traumatic encephalopathy	27
Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study	27
HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing	27
Tau immunotherapy is associated with glial responses in FTLD-tau	27
Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia	26
Transmission of cervid prions to humanized mice demonstrates the zoonotic potential of CWD	26
CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles	25
ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease	25
Oligodendroglia heterogeneity in the human central nervous system	25
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling	25
FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease	25
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis	25
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification	25
Epigenomic, genomic, and transcriptomic landscape of schwannomatosis	25
Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies	25
Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations	25
The oncogenic fusion landscape in pediatric CNS neoplasms	25
Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains	24
Vagus nerve inflammation contributes to dysautonomia in COVID-19	24
Wolframin is a novel regulator of tau pathology and neurodegeneration	24
Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome	24
Heterogeneity of white matter astrocytes in the human brain	23
TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury	23
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes	23
Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns	23
MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis	22
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology	22
Association of small vessel disease with tau pathology	22
Association of probable REM sleep behavior disorder with pathology and years of contact sports play in chronic traumatic encephalopathy	22
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges	22
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease	22
Oligosarcomas, IDH-mutant are distinct and aggressive	22
Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions	22
Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex	22
Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy	22
DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner	21
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease	21
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma	21
Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old	21
Consequences of variability in α-synuclein fibril structure on strain biology	21
TREM2 expression in the brain and biological fluids in prion diseases	21
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease	21
DNA methylation-based classification of malformations of cortical development in the human brain	21
Alzheimer disease neuropathology in a patient previously treated with aducanumab	21
New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy	21
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity	20
EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma	20
Intellectual disability: dendritic anomalies and emerging genetic perspectives	20
TDP-43 interacts with pathological τ protein in Alzheimer’s disease	20
Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease	20
Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis	20
Cross-regional homeostatic and reactive glial signatures in multiple sclerosis	20
Genome-wide association study and functional validation implicates JADE1 in tauopathy	19
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut	19
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission	19
Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt–Jakob disease	19
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to ‘Polymorphous low-grade neuroepithelial tumor of the young’	18
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types	18
An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD	18

LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies	18
Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease	18
Evidence of disrupted rhombic lip development in the pathogenesis of Dandy–Walker malformation	18
PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression	18
Genetics of synucleins in neurodegenerative diseases	17
Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations	17
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas	17
Histopathology of the cerebellar cortex in essential tremor and other neurodegenerative motor disorders: comparative analysis of 320 brains	17
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease	17
Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis	17
Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer’s disease	17
Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum	17
Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies	16
A network of core and subtype-specific gene expression programs in myositis	16
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies	16
Signature laminar distributions of pathology in frontotemporal lobar degeneration	16
TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy	16
A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations	16
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1	16
Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities	16
α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders	16
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients	16
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers	16
Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions	16
Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults	15
Molecular characterization of DICER1-mutated pituitary blastoma	15
ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance	15
Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer’s disease (AD) mouse model and is increased at early stage in sporadic AD brain	15
Targeting fibroblast growth factor receptors to combat aggressive ependymoma	15
Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia	15
Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis	15
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype	15
The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma	15
Antibodies to MOG in CSF only: pathological findings support the diagnostic value	15
Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo	15
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1	15
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas	15
Environmental and host factors that contribute to prion strain evolution	14
Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity	14
Concussion leads to widespread axonal sodium channel loss and disruption of the node of Ranvier	14
Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer’s disease neuropathologic change	14
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state	14
Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis	14
Intratumor and informatic heterogeneity influence meningioma molecular classification	14
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice	14
Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synuclein	14
Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex	14
Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD	14
Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice	13
Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau	13
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13	13
Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old	13
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy	13
Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration	13
Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum	13
Inflammation and the pathological progression of Alzheimer’s disease are associated with low circulating choline levels	13
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies	13
TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia	13
Early white matter pathology in the fornix of the limbic system in Huntington disease	13
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma	13
DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival	13
Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma	13
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation	13
C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma	12
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma	12
A recurrent homozygous ACTN2 variant associated with core myopathy	12
Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes	12
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma	12
Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma	12
Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome	12
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis	12
Mutation ∆K281 in MAPT causes Pick’s disease	11
Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI	11
Validation of the new pathology staging system for progressive supranuclear palsy	11
Brain pathologies are associated with both the rate and variability of declining motor function in older adults	11
Amyotrophic lateral sclerosis is over-represented in two Huntington’s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion	11
Plasma biomarkers for prediction of Alzheimer’s disease neuropathologic change	11
Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers	11
DTYMK is essential for genome integrity and neuronal survival	11
PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD	11
Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis	11
ATP10B variants in Parkinson’s disease: a large cohort study in Chinese mainland population	10
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification	10
Neuropathology of central nervous system involvement in TTR amyloidosis	10
Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology	10
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy	10
Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline	10
Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis	10
C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD	10
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas	10
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease	10
Evidence of traumatic brain injury in headbutting bovids	10
Microglial contribution to the pathology of neurodevelopmental disorders in humans	10
DICER1 syndrome in a young adult with pituitary blastoma	10
Phenotypic diversity in ALS and the role of poly-conformational protein misfolding	10